S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
2 Long-Term EV Plays Trading Under $20
Biden's Plan to Confiscate Your Cash? (Ad)
Are These 3 Video Game Stocks Now In Play?
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
2 Long-Term EV Plays Trading Under $20
Biden's Plan to Confiscate Your Cash? (Ad)
Are These 3 Video Game Stocks Now In Play?
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
2 Long-Term EV Plays Trading Under $20
Biden's Plan to Confiscate Your Cash? (Ad)
Are These 3 Video Game Stocks Now In Play?
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
MUST WATCH: Unusual 3-second financial maneuver (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
2 Long-Term EV Plays Trading Under $20
Biden's Plan to Confiscate Your Cash? (Ad)
Are These 3 Video Game Stocks Now In Play?
Agilent Technologies Proves Its Worth VS Illumina 
Target’s Results Cap Upside Potential For Retail Stocks 
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Egypt's central bank governor resigns as economic woes mount
MUST WATCH: Unusual 3-second financial maneuver (Ad)
NASDAQ:RMTI

Rockwell Medical - RMTI Stock Forecast, Price & News

$2.05
-0.01 (-0.49%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.97
$2.13
50-Day Range
$1.20
$2.11
52-Week Range
$1.17
$7.70
Volume
80,075 shs
Average Volume
108,242 shs
Market Capitalization
$19.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.00

Rockwell Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,509.8% Upside
$33.00 Price Target
Short Interest
Healthy
1.84% of Float Sold Short
Dividend Strength
N/A
Sustainability
-2.35
Upright™ Environmental Score
News Sentiment
0.69mentions of Rockwell Medical in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($3.56) to ($3.92) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.22 out of 5 stars

Medical Sector

426th out of 1,122 stocks

Pharmaceutical Preparations Industry

212th out of 551 stocks

RMTI stock logo

About Rockwell Medical (NASDAQ:RMTI) Stock

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on Rockwell Medical in a report on Wednesday. They set a "hold" rating for the company.

Rockwell Medical Stock Performance

RMTI Stock opened at $2.06 on Wednesday. The company has a current ratio of 1.27, a quick ratio of 0.98 and a debt-to-equity ratio of 5.21. The business's fifty day moving average price is $1.42 and its two-hundred day moving average price is $2.81. Rockwell Medical has a fifty-two week low of $1.17 and a fifty-two week high of $7.70.

Rockwell Medical (NASDAQ:RMTI - Get Rating) last posted its quarterly earnings data on Monday, August 15th. The company reported ($0.56) earnings per share for the quarter, topping the consensus estimate of ($0.81) by $0.25. Rockwell Medical had a negative return on equity of 474.88% and a negative net margin of 51.27%. During the same quarter in the previous year, the business posted ($0.99) EPS. As a group, analysts anticipate that Rockwell Medical will post -3.56 EPS for the current year.

Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

RMTI Stock News Headlines

StockNews.com Begins Coverage on Rockwell Medical (NASDAQ:RMTI)
Rockwell Medical (NASDAQ:RMTI) Issues Quarterly Earnings Results
Rockwell Medical Announces Second Quarter 2022 Results
Rockwell Medical (RMTI) Set to Announce Earnings on Monday
Rockwell Medical drops 14% as CEO departs
Rockwell Medical launches $15M at-market offering
Rockwell Medical Reports Q1 Loss of $0.84/sh
See More Headlines
Receive RMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rockwell Medical and its competitors with MarketBeat's FREE daily newsletter.

RMTI Company Calendar

Last Earnings
8/15/2022
Today
8/17/2022
Next Earnings (Estimated)
11/21/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:RMTI
CUSIP
77437410
Employees
300
Year Founded
1995

Price Target and Rating

Average Stock Price Forecast
$33.00
High Stock Price Forecast
$33.00
Low Stock Price Forecast
$33.00
Forecasted Upside/Downside
+1,509.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-32,670,000.00
Pretax Margin
-51.27%

Debt

Sales & Book Value

Annual Sales
$61.93 million
Book Value
$0.30 per share

Miscellaneous

Free Float
9,134,000
Market Cap
$19.28 million
Optionable
Optionable
Beta
1.21

Social Links


Key Executives

  • Mr. Russell L. Skibsted M.B.A. (Age 63)
    Exec. VP, CFO & Chief Bus. Officer
    Comp: $598.92k
  • Dr. Mark Strobeck Ph.D. (Age 51)
    Pres, CEO & Director
  • Mr. Michael DeYoung
    VP of Operations
  • Mr. Paul E. McGarry (Age 54)
    VP, Corp. Controller & Principal Accounting Officer
  • Ms. Megan C. Timmins (Age 49)
    Sr. VP, Gen. Counsel & Corp. Sec.
  • Mr. James A. McCarthy
    Sr. VP of Bus. & Corp. Devel.
  • Mr. Timothy T. Chole
    Sr. VP of Sales & Marketing
  • Dr. Marc L. Hoffman (Age 61)
    Chief Medical Officer
  • Mr. David J. Kull (Age 54)
    Sec.
  • Mr. Jason Finkelstein
    Investor Relations Representative













RMTI Stock - Frequently Asked Questions

Should I buy or sell Rockwell Medical stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rockwell Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" RMTI shares.
View RMTI analyst ratings
or view top-rated stocks.

What is Rockwell Medical's stock price forecast for 2022?

1 equities research analysts have issued 1 year price targets for Rockwell Medical's shares. Their RMTI share price forecasts range from $33.00 to $33.00. On average, they predict the company's share price to reach $33.00 in the next year. This suggests a possible upside of 1,509.8% from the stock's current price.
View analysts price targets for RMTI
or view top-rated stocks among Wall Street analysts.

How have RMTI shares performed in 2022?

Rockwell Medical's stock was trading at $4.51 on January 1st, 2022. Since then, RMTI stock has decreased by 54.5% and is now trading at $2.05.
View the best growth stocks for 2022 here
.

When is Rockwell Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 21st 2022.
View our RMTI earnings forecast
.

How were Rockwell Medical's earnings last quarter?

Rockwell Medical, Inc. (NASDAQ:RMTI) announced its quarterly earnings data on Monday, August, 15th. The company reported ($0.56) earnings per share for the quarter, topping the consensus estimate of ($0.81) by $0.25. Rockwell Medical had a negative net margin of 43.33% and a negative trailing twelve-month return on equity of 974.30%. During the same period in the prior year, the firm earned ($0.99) EPS.

When did Rockwell Medical's stock split?

Shares of Rockwell Medical reverse split on Friday, May 13th 2022. The 1-11 reverse split was announced on Friday, May 13th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 13th 2022. An investor that had 100 shares of stock prior to the reverse split would have 9 shares after the split.

What is Robert L. Chioini's approval rating as Rockwell Medical's CEO?

6 employees have rated Rockwell Medical Chief Executive Officer Robert L. Chioini on Glassdoor.com. Robert L. Chioini has an approval rating of 22% among the company's employees. This puts Robert L. Chioini in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rockwell Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rockwell Medical investors own include Immunomedics (IMMU), JinkoSolar (JKS), Seagen (SGEN), Geron (GERN), OPKO Health (OPK), Amarin (AMRN), Gilead Sciences (GILD), ImmunoGen (IMGN), Sorrento Therapeutics (SRNE) and VBI Vaccines (VBIV).

What is Rockwell Medical's stock symbol?

Rockwell Medical trades on the NASDAQ under the ticker symbol "RMTI."

Who are Rockwell Medical's major shareholders?

Rockwell Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Richmond Brothers Inc. (6.79%), Perkins Capital Management Inc. (3.78%), Verdence Capital Advisors LLC (0.76%), Millennium Management LLC (0.52%), Renaissance Technologies LLC (0.37%) and SkyOak Wealth LLC (0.21%). Insiders that own company stock include David S Richmond and Russell H Ellison.
View institutional ownership trends
.

How do I buy shares of Rockwell Medical?

Shares of RMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rockwell Medical's stock price today?

One share of RMTI stock can currently be purchased for approximately $2.05.

How much money does Rockwell Medical make?

Rockwell Medical (NASDAQ:RMTI) has a market capitalization of $19.28 million and generates $61.93 million in revenue each year.

How many employees does Rockwell Medical have?

The company employs 300 workers across the globe.

When was Rockwell Medical founded?

Rockwell Medical was founded in 1995.

How can I contact Rockwell Medical?

Rockwell Medical's mailing address is 411 HACKENSACK AVENUE SUITE 501, HACKENSACK NJ, 07601. The official website for the company is www.rockwellmed.com. The company can be reached via phone at (248) 960-9009, via email at invest@rockwellmed.com, or via fax at 248-960-9119.

This page (NASDAQ:RMTI) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.